Commerce.com, Inc. filed a current report on November 5, 2026, disclosing the upcoming departure of Chief Financial Officer and Chief Operating Officer Daniel Lentz, the appointment of Tyler Duncan as Interim Chief Financial Officer effective November 13, 2026, and retention arrangements for certain members …
Brady Corporation filed a Form 8-K on November 5, 2026, disclosing that on November 4, 2026, it entered into and closed a Share Exchange Agreement with William H. Brady III, converting his entire Class B Common Stock position into newly issued Class A Common …
BKV Corporation filed a Form 8-K with the U.S. Securities and Exchange Commission on November 5, 2026, reporting third-quarter 2026 results of operations and furnishing an investor presentation under Regulation FD.
Resolute Holdings Management, Inc. filed a Form 8-K on November 5, 2026, disclosing a board-authorized increase to its share repurchase program to $100.0 million and announcing financial results for the three and nine months ended September 30, 2026.
GPGI, Inc. filed a Form 8-K with the U.S. Securities and Exchange Commission on November 5, 2026, announcing its financial results for the three and nine months ended September 30, 2026, and declaring a quarterly cash dividend.
Zoetis Inc. filed a current report on Form 8-K with the SEC on November 5, 2026, disclosing that the company issued a press release on that date reporting its financial results for the third quarter of 2026 and its guidance for the full year …
Latigo Biotherapeutics, Inc. filed a Form 8-K on November 5, 2026, disclosing the appointment of Todd Smith as President and Chief Executive Officer effective November 3, 2026, the departure of Nima Farzan from those roles and from the Board, related compensation arrangements, and the …
1stdibs.com, Inc. filed a Form 8-K on November 5, 2026, disclosing a CEO transition plan, compensation arrangements for both the outgoing and incoming chief executive, and the announcement of third-quarter 2026 financial results.
ANI Pharmaceuticals, Inc. filed a Form 8-K on November 5, 2026, announcing its financial results for the third quarter ended September 30, 2026, and providing a presentation covering those results alongside the proposed Egetis Therapeutics acquisition.
Tripadvisor, Inc. filed a Form 8-K on November 5, 2026, disclosing that it issued a press release announcing preliminary financial results for the three and nine months ended September 30, 2026.